These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36880948)

  • 21. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
    Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
    medRxiv; 2022 Feb; ():. PubMed ID: 35169811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
    Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
    Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
    Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
    Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Clinical Outcomes and Imaging Features in Hospitalized Patients with SARS-CoV-2 Omicron Subvariants.
    Lee JE; Hwang M; Kim YH; Chung MJ; Jeong WG; Sim BH; Jeong YJ
    Radiology; 2023 Jul; 308(1):e230653. PubMed ID: 37462497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Analysis of Clinical and CT Findings in Patients with SARS-CoV-2 Original Strain, Delta and Omicron Variants.
    Han X; Chen J; Chen L; Jia X; Fan Y; Zheng Y; Alwalid O; Liu J; Li Y; Li N; Gu J; Wang J; Shi H
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey on chest CT findings in COVID-19 patients in Okinawa, Japan: differences between the delta and omicron variants.
    Tsuchiya N; Yonamine E; Iraha S; Takara M; Oshiro Y; Tetsuhiro M; Murayama S; Kinoshita R; Sato M; Nishikuramori Y; Takara H; Akamine T; Morita H; Matayoshi T; Chinen Y; Nishie A
    Sci Rep; 2023 Nov; 13(1):20373. PubMed ID: 37990038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants.
    de Michelena P; Torres I; Ferrando EC; Olea B; González-Candelas F; Sánchez G; Navarro D
    Clin Microbiol Infect; 2023 Feb; 29(2):256.e1-256.e4. PubMed ID: 36115649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1).
    Beraud G; Bouetard L; Civljak R; Michon J; Tulek N; Lejeune S; Millot R; Garchet-Beaudron A; Lefebvre M; Velikov P; Festou B; Abgrall S; Lizatovic IK; Baldolli A; Esmer H; Blanchi S; Froidevaux G; Kapincheva N; Faucher JF; Duvnjak M; Afşar E; Švitek L; Yarimoglu S; Yarimoglu R; Janssen C; Epaulard O;
    Clin Microbiol Infect; 2023 May; 29(5):642-650. PubMed ID: 36587737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between vaccination status and COVID-19-related health outcomes among community-dwelling COVID-19 patients in Nara, Japan.
    Tomioka K; Uno K; Yamada M
    Environ Health Prev Med; 2023; 28():7. PubMed ID: 36682815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital.
    Obeid D; Al-Qahtani A; Almaghrabi R; Alghamdi S; Alsanea M; Alahideb B; Almutairi S; Alsuwairi F; Al-Abdulkareem M; Asiri M; Alshukairi A; Alkahtany J; Altamimi S; Mutabagani M; Althawadi S; Alanzi F; Alhamlan F
    J Infect Public Health; 2023 Feb; 16(2):171-181. PubMed ID: 36543031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
    Link-Gelles R; Levy ME; Natarajan K; Reese SE; Naleway AL; Grannis SJ; Klein NP; DeSilva MB; Ong TC; Gaglani M; Hartmann E; Dickerson M; Stenehjem E; Kharbanda AB; Han J; Spark TL; Irving SA; Dixon BE; Zerbo O; McEvoy CE; Rao S; Raiyani C; Sloan-Aagard C; Patel P; Dascomb K; Uhlemann AC; Dunne MM; Fadel WF; Lewis N; Barron MA; Murthy K; Nanez J; Griggs EP; Grisel N; Annavajhala MK; Akinseye A; Valvi NR; Goddard K; Mamawala M; Arndorfer J; Yang DH; Embí PJ; Fireman B; Ball SW; Tenforde MW
    JAMA Netw Open; 2023 Mar; 6(3):e232598. PubMed ID: 36920396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Ferdinands JM; Rao S; Dixon BE; Mitchell PK; DeSilva MB; Irving SA; Lewis N; Natarajan K; Stenehjem E; Grannis SJ; Han J; McEvoy C; Ong TC; Naleway AL; Reese SE; Embi PJ; Dascomb K; Klein NP; Griggs EP; Konatham D; Kharbanda AB; Yang DH; Fadel WF; Grisel N; Goddard K; Patel P; Liao IC; Birch R; Valvi NR; Reynolds S; Arndorfer J; Zerbo O; Dickerson M; Murthy K; Williams J; Bozio CH; Blanton L; Verani JR; Schrag SJ; Dalton AF; Wondimu MH; Link-Gelles R; Azziz-Baumgartner E; Barron MA; Gaglani M; Thompson MG; Fireman B
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):255-263. PubMed ID: 35176007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.
    Lai M; Wang K; Ding C; Yin Y; Lin X; Xu C; Hu Z; Peng Z
    Ann Clin Microbiol Antimicrob; 2023 Mar; 22(1):22. PubMed ID: 36944961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
    PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods.
    Shoji K; Tsuzuki S; Akiyama T; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Yamada M; Ozawa N; Yamaguchi K; Miyairi I; Ohmagari N
    J Infect Chemother; 2023 Jan; 29(1):33-38. PubMed ID: 36103949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study.
    Wang J; Dong H; Zhao J; Li T; Wang M; Zhou C; Mu H
    Front Microbiol; 2023; 14():1096022. PubMed ID: 37065120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination].
    Varea-Jiménez E; Cano EA; Vega-Piris L; Sánchez EVM; Mazagatos C; Rodríguez-Alarcón LGSM; Casas I; Moros MJS; Iglesias-Caballero M; Vazquez-Morón S; Larrauri A; Monge S
    Enferm Infecc Microbiol Clin; 2022 Dec; ():. PubMed ID: 36506460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
    Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
    Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.